What are the goals of drug treatment for infantile hemangiomas?

Updated: Nov 09, 2020
  • Author: Richard J Antaya, MD; Chief Editor: William D James, MD  more...
  • Print

The goals of pharmacotherapy for infantile hemangiomas are to reduce morbidity and mortality and to prevent complications. Note that only propranolol oral solution (Hemangeol) is approved for treatment of infantile hemangiomas by the FDA, and all other therapies should be considered off-label usage.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!